Remote Jobs at DBV Technologies
DBV Technologies
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $30M Post-IPO Secondary - DBV Technologies on 2025-10
Biotechnology • Pharmaceuticals
DBV Technologies is a global clinical-stage biopharmaceutical company developing epicutaneous immunotherapy to treat food allergies and other immune-mediated diseases. Founded by pediatricians, the company is advancing its proprietary VIASKIN® patch technology through clinical trials—including Phase 3 studies for a peanut allergy patch (DBV712) and earlier-stage programs for milk allergy (DBV135)—with the goal of re-educating the immune system using controlled skin exposure to antigens.
💼 Job Title
🌍 Your Location
💵 Minimum Salary
⚪️ Experience
Is on LinkedIn?4 total jobs
2 new jobs this week ⚡️
0% are NOT on LinkedIn 🚫
Looking for a remote job? Search our job board for 100,000+ remote jobs
